1) 田中京子, 進 伸幸, 青木大輔 : 子宮体癌は増えている.臨婦産64 : 1598─1603, 2010
2) 塩沢丹里, 小西郁生 : 子宮体癌の発癌機構研究のトピックス.臨婦産61 : 159─167, 2007
3) Fu-Shing Liu : Molecular carcinogenesis of endometrial cancer. Taiwanese J Obstet Gynecol 46 : 26─32, 2007
4) Kanaya T, Kyo S, Maida Y, et al : Frequent hypermethylation of MLH1 promorter in normal endometrium of patients with endometrial cancers. Oncogene 22 : 2352─2360, 2003
5) Lim PC, Tester D, Cliby W, et al : Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability. Clinical Cancer Research 2 : 1907─1911, 1996
6) Horowitz N, Pinto K, Mutch DG, et al : Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. Gynecologic Oncology 86 : 62─68, 2002
7) Salvesen HB, MacDonald N, Ryan A, et al : Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clinical Cancer Research 6 : 3607─3613, 2000
8) Simpkins SB, Bocker T, Swisher EM, et al : MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Human Molecular Genetics 8 : 661─666, 1999
9) Ju W, Park HM, Lee SN, et al : Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid adenocarcinoma. J Obstet Gynecol Res 32 : 454─460, 2006
10) Esteller M, Catasus L, Matias-Guiu X, et al : hMLH1 promoter hyper methylation is an early event in human endometrial tumorigenesis. American Journal of Pathology 155 : 1767─1771, 1999
11) Yoshizaki T, Enomoto T, Fujita M, et al : Frequent inactivation of RUNX3 in endometrial carcinoma. Gynecologic Oncology 110 : 439─444, 2008
12) Peiro G, Diebold J, Lohse P, et al : Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. Human Pathology 33 : 347─354, 2002